Chapter 7 Enzyme Mechanism & Control (1)

Embed Size (px)

Citation preview

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    1/37

    Paul D. Adams University of Arkansas

    Mary K. Campbell

    Shawn O. Farrellhttp://academic.cengage.com/chemistry/campbell

    Chapter SevenThe Behavior of Proteins:

    Enzymes, Mechanisms, and Control

    http://academic.cengage.com/chemistry/campbellhttp://academic.cengage.com/chemistry/campbell
  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    2/37

    Allosteric Enzymes

    Allosteric: Greek allo+ steric, other shape

    Allosteric enzyme: an oligomer whose biological activity is affected byother substances binding to it

    these substances change the enzymes activity by altering the

    conformation(s) of its 4structure

    Allosteric effector: a substance that modifies the behavior of an allosteric

    enzyme; may be an

    allosteric inhibitor

    allosteric activator

    Aspartate transcarbamoylase (ATCase)

    feedback inhibition

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    3/37

    Feedback Inhibition

    Formation of product

    inhibits its continuedproduction

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    4/37

    ATCase

    Rate of ATCase catalysis vs

    substrate concentration

    Sigmoidal shape of curve describes

    allosteric behavior

    ATCase catalysis in presenceof CTP; ATP

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    5/37

    ATCase (Contd)

    Organization of ATCase

    catalytic unit: 6 subunitsorganized into 2 trimers

    regulatory unit: 6 subunitsorganized into 3 dimers

    Catalytic subunits can beseparated from regulatorysubunits by a compound thatreacts with cysteine (p-hydroxymercuribenzoate)

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    6/37

    Allosteric Enzymes (Contd)

    Two types of allosteric enzyme systems exist

    Note: for an allosteric enzyme, the substrateconcentration at one-half Vmax is called the K0.5

    K system: an enzyme for which an inhibitor oractivators alters K0.5

    V system: an enzyme for which an inhibitor oractivator alters Vmax but not K0.5

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    7/37

    Allosteric Enzymes (Contd)

    The key to allosteric behavior is the existence of multiple

    forms for the 4structure of the enzyme allosteric effector: a substance that modifies the 4

    structure of an allosteric enzyme

    homotropic effects: allosteric interactions that occur

    when several identical molecules are bound to theprotein; e.g., the binding of aspartate to ATCase

    heterotropic effects: allosteric interactions that occurwhen different substances are bound to the protein;e.g., inhibition of ATCase by CTP and activation byATP

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    8/37

    The Concerted Model

    Wyman, Monod, and Changeux - 1965

    The enzyme has two conformations

    R (relaxed): binds substrate tightly; the active form

    T (tight or taut): binds substrate less tightly; the

    inactive form in the absence of substrate, most enzyme molecules

    are in the T (inactive) form

    the presence of substrate shifts the equilibrium from

    the T (inactive) form to the R (active) form in changing from T to R and vice versa, all subunits

    change conformation simultaneously; all changes areconcerted

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    9/37

    Concerted Model (Contd)

    A model represented by a protein having two conformations

    Active (R) form-Relaxed binds substrate tightly, Inactive (T) form-Tight (taut) binds substrate less tightly both change from T to R atthe same time

    Also called the concerted model

    Substrate binding shifts equilib. To the relaxed state.

    Any unbound R is removed KR

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    10/37

    Concerted Model (Contd)

    The model explains the sigmoidal effects

    Higher L means higher favorability of free T form

    Higher c means higher affinity between S and R form,more sigmoidal as well.

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    11/37

    Concerted Model (Contd)

    An allosteric activator (A) binds to and stabilizes the R

    (active) form An allosteric inhibitor (I) binds to and stabilizes the T

    (inactive) form

    Effect ofbindingactivatorsand inhibitors

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    12/37

    Sequential Model (Contd)

    Main Feature of Model:

    the binding of substrate induces a conformationalchange from the T form to the R form

    the change in conformation is induced by the fit of thesubstrate to the enzyme, as per the induced-fit modelof substrate binding

    sequential model represents cooperativity

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    13/37

    Sequential Model (Contd)

    Sequential model for cooperative binding of substrate to an allosteric enzyme

    R form is favored by allosteric activator

    Allosteric inhibition also occurs by the induced-fit mechanism

    Unique feature of Sequential Model of behavior:

    Negative cooperativity- Induced conformational changes that make the enzyme

    less likely to bind more molecules of the same type.

    Sequential Model:

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    14/37

    Control of Enzyme Activity via Phosphorylation

    The side chain -OH groups

    of Ser, Thr, and Tyr canform phosphate esters

    Phosphorylation by ATP can

    convert an inactiveprecursor into an activeenzyme

    Membrane transport is acommon example

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    15/37

    Membrane Transport

    Source of PO4 is ATP

    When ATP is hydrolyzed, energy released that allows other

    energetically unfavorable reactions to take place

    PO4 is donated to residue in protein by protein kinases

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    16/37

    Zymogens

    Zymogen: Inactive precursor of an enzyme where cleavage

    of one or more covalent bonds transforms it into the activeenzyme

    Chymotrypsinogen

    synthesized and stored in the pancreas

    a single polypeptide chain of 245 amino acid residuescross linked by five disulfide (-S-S-) bonds

    when secreted into the small intestine, the digestiveenzyme trypsin cleaves a 15 unit polypeptide from the N-terminal end to give -chymotrypsin

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    17/37

    Activation of chymotrypsin

    Activation of chymotrypsinogen by proteolysis

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    18/37

    Chymotrypsin

    A15-unit polypeptide remains bound to -chymotrypsin by

    a single disulfide bond -chymotrypsin catalyzes the hydrolysis of two dipeptide

    fragments to give -chymotrypsin

    -chymotrypsin consists of three polypeptide chains joined

    by two of the five original disulfide bonds changes in 1structure that accompany the change from

    chymotrypsinogen to -chymotrypsin result in changes in

    2- and 3structure as well.

    -chymotrypsin is enzymatically active because of its 2

    -and 3structure, just as chymotrypsinogen was inactivebecause of its 2- and 3structure

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    19/37

    The Active Site

    Some important questions to ask about enzyme mode of action:

    Which amino acid residues on an enzyme are in the active siteand catalyze the reaction?

    What is the spatial relationship of the essential amino acidsresidues in the active site?

    What is the mechanism by which the essential amino acidresidues catalyze the reaction?

    As a model, we consider chymotrypsin, an enzyme of thedigestive system that catalyzes the selective hydrolysis ofpeptide bonds in which the carboxyl group is contributed byPhe or Tyr

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    20/37

    Kinetics of Chymotrypsin Reaction

    p-nitrophenyl acetate is

    hydrolyzed bychymotrypsin in 2stages.

    At the end of stage 1,

    the p-nitrophenolate ionis released.

    At stage 2, acyl-enzymeintermediate ishydrolyzed and acetate(Product) isreleasedfree enzyme

    is regenerated

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    21/37

    Chymotrypsin

    Reaction with a model substrate

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    22/37

    Chymotrypsin (Contd)

    Chymotrypsin is a serine protease

    DIPF inactivates chymotrypsin by reacting withserine-195, verifying that this residue is at the active

    site

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    23/37

    Chymotrypsin (Contd)

    H57 also critical for

    activation of enzyme

    Can be chemically

    labeled by TPCK

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    24/37

    Chymotrypsin (Contd)

    Because Ser-195 and His-57 are required for activity,

    they must be close to each other in the active site

    Results of x-ray crystallography show the definitearrangement of amino acids at the active site

    In addition to His-57 and Ser-195, Asp-102 is alsoinvolved in catalysis at the active site

    The folding of the chymotrypsin backbone, mostly inantiparallel pleated sheet array, positions the essential aminoacids around the active-site pocket

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    25/37

    Chymotrypsin (Contd)

    The active site of

    chymotrypsin showsproximity of 2 reactivea.a.

    M h i f A ti f C iti l A i A id i

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    26/37

    Mechanism of Action of Critical Amino Acids inChymotrypsin

    Serine oxygen is nucleophile

    Attacks carbonyl group of peptide bond

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    27/37

    Catalytic Mechanisms

    General acid-base catalysis: depends on donation

    and acceptance of protons (proton transfer reactions)

    Nucleophilic substitution catalysts- Nucleophilicelectron-rich atom attacks electron deficient atom.

    same type of chemistry can occur at active site of

    enzyme: SN1, SN2

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    28/37

    Catalytic Mechanisms (Contd)

    Lewis acid/base reactions

    Lewis acid: an electron pair acceptor

    Lewis base: an electron pair donor

    Lewis acids such as Mn2+, Mg2+, and Zn2+ are essentialcomponents of many enzymes (metal ion catalysts)

    carboxypeptidase A requires Zn2+ for activity

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    29/37

    Catalytic Mechanisms (Contd)

    Zn2+ of

    carboxypeptidase iscomplexed with:

    The imidazole sidechains of His-69 andHis-196 and the

    carboxylate sidechain of Glu-72

    Activates the

    carbonyl group fornucleophilic acylsubstitution

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    30/37

    Enzyme Specificity

    Absolute specificity: catalyzes the reaction of one unique

    substrate to a particular product

    Relative specificity: catalyzes the reaction of structurallyrelated substrates to give structurally related products

    Stereospecificity: catalyzes a reaction in which onestereoisomer is reacted or formed in preference to all othersthat might be reacted or formed

    example: hydration of a cis alkene (but not its transisomer) to give an R alcohol (but not the S alcohol)

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    31/37

    Asymmetric binding

    Enzymes can be

    stereospecific(Specificity whereoptical activity may paya role)

    Binding sites on enzymes

    must be asymmetric

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    32/37

    Active Sites and Transition States

    Enzyme catalysis

    an enzyme provides an alternative pathway with a loweractivation energy

    the transition state often has a different shape than either thesubstrate(s) or the product(s)

    True nature of transition state is a chemical species that is

    intermediate in structure between the substrate and the product. Transition state analog: a substance whose shape mimics that of atransition state

    In 1969 Jenks proposed that

    an immunogen would elicit an antibody with catalytic activity if

    the immunogen mimicked the transition state of the reaction the first catalytic antibody or abzyme was created in 1986 by

    Lerner and Schultz

    *(Biochemical Connections, p. 196)

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    33/37

    Coenzymes

    Coenzyme: a nonprotein substance that takes part in an

    enzymatic reaction and is regenerated for further reaction metal ions- can behave as coordination compounds. (Zn2+,

    Fe2+)

    organic compounds, many of which are vitamins or are

    metabolically related to vitamins (Table 7.1).

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    34/37

    NAD+/NADH

    Nicotinamide adenine

    dinucleotide (NAD+

    ) is usedin many redox reactions inbiology.

    Contains:1) nicotinamide ring

    2) Adenine ring

    3) 2 sugar-phosphate groups

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    35/37

    NAD+/NADH (Contd)

    NAD+ is a two-electron oxidizing agent, and is

    reduced to NADH

    Nicotinamide ring is where reduction-oxidation

    occurs

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    36/37

    B6 Vitamins

    The B6 vitamins are coenzymes involved in amino group

    transfer from one molecule to another. Important in amino acid biosynthesis

  • 8/3/2019 Chapter 7 Enzyme Mechanism & Control (1)

    37/37

    Pyridoxal Phosphate

    Pyridoxal and pyridoxamine phosphates are involved in

    the transfer of amino groups in a reaction calledtransamination

    Figure 7.21 p. 197